全文获取类型
收费全文 | 12349篇 |
免费 | 710篇 |
国内免费 | 163篇 |
专业分类
耳鼻咽喉 | 115篇 |
儿科学 | 362篇 |
妇产科学 | 219篇 |
基础医学 | 1299篇 |
口腔科学 | 560篇 |
临床医学 | 1099篇 |
内科学 | 2833篇 |
皮肤病学 | 224篇 |
神经病学 | 695篇 |
特种医学 | 454篇 |
外国民族医学 | 4篇 |
外科学 | 1809篇 |
综合类 | 560篇 |
一般理论 | 10篇 |
预防医学 | 776篇 |
眼科学 | 321篇 |
药学 | 1095篇 |
中国医学 | 68篇 |
肿瘤学 | 719篇 |
出版年
2024年 | 13篇 |
2023年 | 188篇 |
2022年 | 588篇 |
2021年 | 799篇 |
2020年 | 408篇 |
2019年 | 488篇 |
2018年 | 608篇 |
2017年 | 340篇 |
2016年 | 390篇 |
2015年 | 396篇 |
2014年 | 526篇 |
2013年 | 661篇 |
2012年 | 925篇 |
2011年 | 917篇 |
2010年 | 482篇 |
2009年 | 416篇 |
2008年 | 604篇 |
2007年 | 657篇 |
2006年 | 548篇 |
2005年 | 550篇 |
2004年 | 536篇 |
2003年 | 418篇 |
2002年 | 430篇 |
2001年 | 96篇 |
2000年 | 74篇 |
1999年 | 71篇 |
1998年 | 126篇 |
1997年 | 87篇 |
1996年 | 73篇 |
1995年 | 86篇 |
1994年 | 65篇 |
1993年 | 63篇 |
1992年 | 26篇 |
1991年 | 43篇 |
1990年 | 44篇 |
1989年 | 58篇 |
1988年 | 47篇 |
1987年 | 39篇 |
1986年 | 51篇 |
1985年 | 34篇 |
1984年 | 31篇 |
1983年 | 24篇 |
1982年 | 20篇 |
1981年 | 26篇 |
1980年 | 27篇 |
1979年 | 16篇 |
1978年 | 13篇 |
1977年 | 17篇 |
1975年 | 10篇 |
1974年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
Tianli Du Katherine A. Bill Jennifer Ford Mohammed Barawi Richard D. Hayward Amer Alame Richard N. Berri 《American journal of surgery》2018,215(3):472-475
Background
Pancreatic cancer is the fourth leading cause of cancer-related death in United States. We compared Computed Tomography (CT) with pancreas protocol and Endoscopic Ultrasound (EUS) in terms of mass detection, mass size, vascular involvement and lymph node involvement.Methods
We retrospectively evaluated 93 patients. Concordance between CT and EUS, and accuracy of CT and EUS were assessed using a retrospective chart review and statistical analysis.Results
CT and EUS agreed on mass detection in 88% of the cases and mass size in 67% of the cases. They agreed in 74% of cases about the presence or absence of vascular involvement and 82% in lymph node involvement. Cohen's kappa indicated that the concordance between two tests was moderately reliable.Conclusion
CT and EUS agree moderately well in identifying characteristics of pancreatic masses, but discrepancies between the two modalities are common, particularly with respect to involvement of specific blood vessels and lymph nodes. Clinicians should use caution in relying on a single modality to make decisions. 相似文献993.
Amro Mohamed Sedky El-Ghammaz Hoda Ahmed Gadallah Gihan Kamal Mohammed Magdy Maher Mohamad Ayed Mohamad 《Clinical and experimental medicine》2018,18(4):505-512
Programmed death ligand-1 (PD-L1) plays an important role in the immune evasion of cancer cells and, in turn, can influence the outcome of many malignancies. The serum soluble PD-L1 (sPD-L1) levels were measured in diffuse large B cell lymphoma (DLBCL) patients at diagnosis and at end of treatment. Their impact on end of treatment metabolic response was analyzed. Serum sPD-L1 level was significantly elevated in DLBCL patients at diagnosis than in controls (P?<?0.001). Also, serum sPD-L1 level at diagnosis was significantly higher than that at end of treatment (P?<?0.001). Patients who achieved partial response (PR) had significantly higher serum sPD-L1 level at end of treatment than controls (P?<?0.001). In contrast, all patients especially those who achieved complete response (CR) had insignificantly different serum sPD-L1 level at end of treatment than controls (P?=?0.354 and P?=?0.090, respectively). There was a significant difference between serum sPD-L1 level at diagnosis and that at end of treatment in patients who achieved PR and CR (P?=?0.023 and P?<?0.001, respectively). On univariate analysis, presence of comorbidities, Ann Arbor stage IV, high serum sPD-L1 level at diagnosis and high serum sPD-L1 level at end of treatment were significantly associated with achievement of PR (P?=?0.018 and P?=?0.043, P?=?0.045 and P?<?0.001, respectively). On multivariate analysis, serum sPD-L1 levels at diagnosis and at end of treatment were still influencing metabolic response significantly (P?=?0.014 and P?=?0.007, respectively). Serum sPD-L1 is a predictor for metabolic response to immunochemotherapy in DLBCL patients. 相似文献
994.
Genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 variants with insertions or deletions in the reverse transcriptase (RT): multicenter study of patients treated with RT inhibitors 下载免费PDF全文
995.
Robert B. Hawkins J. Hunter Mehaffey Kenan W. Yount Leora T. Yarboro Clifford Fonner Irving L. Kron Mohammed Quader Alan Speir Jeffrey Rich Gorav Ailawadi 《The Journal of thoracic and cardiovascular surgery》2018,155(1):182-188
Objectives
The Centers for Medicare and Medicaid Services plans to institute a 5-year trial of bundled payments for coronary artery bypass grafting through 90 days after discharge. To investigate the impact, we reviewed actual inpatient costs for patients undergoing bypass surgery relative to the target price.Methods
A total of 13,276 Medicare patients with estimated cost data underwent isolated coronary artery bypass grafting from 2008 to 2015 in 18 hospitals over 8 Medicare-defined regions within the Commonwealth of Virginia. Actual 2015 inpatient costs were compared with estimated target prices for each year of the pilot, based on the previous 3 years and stratified by Diagnosis-Related Group.Results
The mean 2015 cost per patient was $50,394 with high variation (range, $27,862-$74,169). On average, hospitals would receive a refund of $17,682 in year 1, but then owe Medicare increasing amounts up to $367,985 in year 5. If 2015 were the final year of the pilot, 13 of the 18 hospitals (72%) would have owed Medicare for cost overruns averaging $614,270 (range, $67,404-$2,102,292). Costs were below the target price at 5 of 18 hospitals, and the Centers for Medicare and Medicaid Services would have paid them an extra $272,355 on average (range, $88,628-$567,429).Conclusions
Hospitals will face immediate financial pressure due to average cost increases of 3.6% per year and an automatic reduction in payment. As regional pricing is phased in, hospitals can expect to owe Medicare increasing amounts. The net effect is shifting of financial risks to hospitals, which could restrict access to care for higher-risk patients. 相似文献996.
Md. Ariful Islam Anisur Rahman Mohammad Abdul Aleem Sheikh Mohammed Shariful Islam 《International journal of mental health and addiction》2016,14(2):154-166
To assess the prevalence of depression and its associated factors among patients with stroke in Bangladesh. We conducted a cross-sectional study among 164 post-stroke patients attending two hospitals in Dhaka city between January and June 2011. Depression was measured using the Hamilton Depression Rating Scale. Factors associated with depression were analyzed using multivariate logistic regression. Results: The prevalence of depression was 70 and 32 % had severe depression. The mean ± sd age of the participants was 58.91 ± 7.03 years. Multivariate regression analysis revealed that factors significantly associated with depression were living in a joint family (OR = 13.5, 95 % CI = 1.3–145.7, p = 0.032), those unable to perform daily activities by themselves (OR = 14.9, 95 % CI = 2.0–108.1, p = 0.008) and those with comorbid dysphasia (OR = 9.5, 95 % CI = 1.0–86.9, p = 0.046) and hypertension (OR = 5.2, 95 % CI = 2.3–15.4, p = 0.012). Depression is a significant health problem among post-stroke patients in Bangladesh. This leads to careful management of depression for social support to achieve better patient outcome. 相似文献
997.
Matthew J. Gazzellone Mehdi Zarrei Christie L. Burton Susan Walker Mohammed Uddin S. M. Shaheen Julie Coste Rageen Rajendram Reva J. Schachter Marlena Colasanto Gregory L. Hanna David R. Rosenberg Noam Soreni Kate D. Fitzgerald Christian R. Marshall Janet A. Buchanan Daniele Merico Paul D. Arnold Stephen W. Scherer 《Journal of Neurodevelopmental Disorders》2016,8(1):36
Background
Obsessive-compulsive disorder (OCD) is a heterogeneous neuropsychiatric condition, thought to have a significant genetic component. When onset occurs in childhood, affected individuals generally exhibit different characteristics from adult-onset OCD, including higher prevalence in males and increased heritability. Since neuropsychiatric conditions are associated with copy number variations (CNVs), we considered their potential role in the etiology of OCD.Methods
We genotyped 307 unrelated pediatric probands with idiopathic OCD (including 174 that were part of complete parent-child trios) and compared their genotypes with those of 3861 population controls, to identify rare CNVs (<0.5 % frequency) of at least 15 kb in size that might contribute to OCD.Results
We uncovered de novo CNVs in 4/174 probands (2.3 %). Our case cohort was enriched for CNVs in genes that encode targets of the fragile X mental retardation protein (nominal p?=?1.85?×?10?03; FDR=0.09), similar to previous findings in autism and schizophrenia. These results also identified deletions or duplications of exons in genes involved in neuronal migration (ASTN2), synapse formation (NLGN1 and PTPRD), and postsynaptic scaffolding (DLGAP1 and DLGAP2), which may be relevant to the pathogenesis of OCD. Four cases had CNVs involving known genomic disorder loci (1q21.1-21.2, 15q11.2-q13.1, 16p13.11, and 17p12). Further, we identified BTBD9 as a candidate gene for OCD. We also sequenced exomes of ten “CNV positive” trios and identified in one an additional plausibly relevant mutation: a 13 bp exonic deletion in DRD4.Conclusions
Our findings suggest that rare CNVs may contribute to the etiology of OCD.998.
Konrad Salata Muzammil Syed Mohamad A. Hussain Rachel Eikelboom Charles de Mestral Subodh Verma Mohammed Al-Omran 《Journal of vascular surgery》2018,67(2):629-636.e2
Objective
The objective of this study was to summarize the literature regarding the effects of renin-angiotensin system blockade (RASB) using angiotensin-converting enzyme inhibitors (ACEis) or angiotensin receptor blockers (ARBs) on human abdominal aortic aneurysm (AAA) growth, rupture, and perioperative mortality.Methods
We conducted a systematic review in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Our review protocol was registered at the International Prospective Register of Systematic Reviews (CRD42016054082). We searched the Cochrane Central Register of Controlled Trials database, MEDLINE, and Embase from inception to 2017 for studies examining the effects of ACEi or ARB treatment on AAA growth, rupture, or perioperative mortality. Review, abstraction, and quality assessment were conducted in duplicate, and a third author resolved discrepancies. We assessed study quality using the Cochrane and Newcastle-Ottawa scales. We used random-effects models to calculate pooled mean differences and odds ratios (ORs) with 95% confidence intervals (CIs). Heterogeneity was quantified using the I2 statistic.Results
Our search yielded 525 articles. One randomized and seven observational studies involving 35,448 patients were included. Inter-rater agreement was excellent (κ = 0.78), and risk of bias was low to moderate. All studies investigated ACEis, three studies investigated ARBs, and two studies included a composite RASB group consisting of ACEi or ARB users. Five studies assessed AAA growth, two assessed rupture rate, and one reported 30-day mortality after elective open repair. There was no difference in AAA growth rate between RASB and control (mean difference, 0.03 mm/y; 95% CI, ?0.40 to 0.46; P = .88; I2 = 60%). No protective effect of RASB (OR, 0.92; 95% CI, 0.72, 1.16; P = .47; I2 = 90%) was demonstrated for AAA rupture. Finally, RASB increased 30-day mortality in patients undergoing elective open AAA repair (OR, 5; 95% CI, 1.4, 27) according to a single well-adjusted study.Conclusions
RASB does not appear to affect AAA growth and rupture rate but increases elective perioperative mortality. The small number of heterogeneous, retrospective studies and limited long-term follow-up preclude a definitive dismissal of RASB as pharmacotherapy for AAA. Prospective, long-term data are needed to clarify the effect of RASB on AAA growth, rupture, and perioperative mortality. 相似文献999.
1000.